Health Care Technology
Company Overview of DNAnexus, Inc.
DNAnexus, Inc. provides cloud-based genome informatics and data management tools for enterprises and organizations that are engaged in the development and delivery of genomic medicine. The company’s platform enables the companies to analyze raw sequencing data; integrate genomic data with clinical and other phenotypic data; and collaborate seamlessly. It serves biopharmaceutical companies, genome centers, diagnostic test providers, and others. The company has a strategic alliance with WuXi NextCODE Genomics. DNAnexus, Inc. was founded in 2009 and is based in Mountain View, California.
1975 West El Camino Real
Mountain View, CA 94040
Founded in 2009
Key Executives for DNAnexus, Inc.
Chief Executive Officer and Director
Co-Founder and Chief Technology Officer
Compensation as of Fiscal Year 2014.
DNAnexus, Inc. Key Developments
WuXi NextCODE Genomics and DNAnexus Form Strategic Alliance
Apr 22 15
WuXi PharmaTech (Cayman) Inc. announced that its wholly owned subsidiary WuXi NextCODE Genomics and DNAnexus have formed a strategic alliance that aims to accelerate the use of genomics to benefit patients worldwide. Now available via a single platform are the sequence data analysis suite that has analyzed more genomes than any other; pioneering Silicon Valley genomics cloud technology; and global, open-access drug discovery and development capabilities serving the life science industry: bringing cloud-based genomics to China and Chinese genomics to the world; speeding the development and delivery of sequence-based diagnostics worldwide; expanding research with collaborations and datasets of unprecedented scope and size; streamlining the development of personalized medicine and companion diagnostics; and leveraging WuXi's genomics and R&D through DNAnexus's global cloud. With WuXi NextCODE's unique genomic database model and clinical and research interfaces directly available on the DNAnexus cloud, users will be able to store and interpret their sequence data and collaborate with colleagues around the world through one platform. The companies will also provide and host the same platform and capabilities within China, in full compliance with local regulations. Users will be able to use their genomic data seamlessly in tandem with the open-access capability and technology platform that WuXi offers to the global pharmaceutical, biopharmaceutical and medical device industry.
Tute Genomics and DNAnexus Team up to Provide Integrated Sample-in, Report-out Genome Analysis Pipeline
Mar 17 15
DNAnexus and Tute Genomics announced an integrated solution for genomic data management. Customers will be able to access the Tute platform and DNAnexus pipelines form either company's cloud environment. DNAnexus provides an enterprise-level solution that combines cloud computing with advanced bioinformatics to power genomic analysis tools. Tute Genomics specializes in genome analysis, creating meaningful reports of an individual's full genomic profile that researchers/clinicians can interpret, or performing association analysis to gain critical insights into the molecular basis of diseases. The collaboration between the two companies allows Tute Genomics to provide its customers with an end-to-end solution, where a clinical researcher can take raw sequence data through genome interpretation in a single step. Clinical researchers can now easily perform best practice data analysis and bring the world's scientific literature together without the hassle of connecting multiple systems, transferring large files or deploying costly local solutions. Web-based tools allow labs or their sequencing providers to upload raw sequence data files directly onto DNAnexus, where these data will be automatically processed through proprietary pipelines developed by Tute to generate 'VCF' data files that can be analyzed using Tute's genome interpretation solutions. As part of this collaboration, DNAnexus has created an export tool, available to customers via the DNAnexus App Library, which enables customers to securely transfer genome variants data into the Tute Genomics solution for downstream analysis, including annotation, interpretation and clinical reporting. Similarly, Tute has created a data uploader, where users of the Tute platform can directly upload FASTQ files from next-generation sequencers, generate variant calls, annotate the genetic variant data, perform association analysis and interactively draft clinical reports on the Tute platform.
DNAnexus, Inc. Presents at Mid-America Healthcare Venture Forum, Mar-11-2015 10:25 AM
Mar 10 15
DNAnexus, Inc. Presents at Mid-America Healthcare Venture Forum, Mar-11-2015 10:25 AM. Venue: Fairmont Chicago, Millennium Park, 200 North Columbus Drive, Chicago, IL 60601, United States. Speakers: David Shaywitz, Chief Medical Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
April 16, 2015